Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from CSPC Pharmaceutical Group ( (HK:1093) ).
CSPC Pharmaceutical Group Limited announced the resignation of Mr. PAN Weidong as Executive Director and his replacement as the Authorized Representative by Dr. LI Chunlei. This change is part of the company’s ongoing management adjustments, which may influence its strategic direction and operational focus.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 165,026,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$88.46B
Learn more about 1093 stock on TipRanks’ Stock Analysis page.